ArriVent BioPharma (AVBP) Profit After Tax (2023 - 2026)
ArriVent BioPharma (AVBP) reported Profit After Tax of -$43.3 million for Q1 2026, up 32.72% on a YoY basis from -$32.6 million in Q1 2025, and down 20.46% sequentially from -$36.0 million in Q4 2025.
ArriVent BioPharma (AVBP) Profit After Tax (2023 - 2026) Analysis & Trends
ArriVent BioPharma (AVBP) has 4 years of Profit After Tax data on file, last reported at -$43.3 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 32.72% year-over-year to -$43.3 million; the trailing twelve-month figure through Mar 2026 stood at -$145.4 million (down 14.1% YoY), and the FY2025 full-year result was -$166.3 million, down 106.62% from the prior year.
- Profit After Tax eased to -$43.3 million in Q1 2026, from -$36.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$12.2 million in Q1 2023 to a low of -$64.4 million in Q1 2025.
- A 4-year average of -$27.7 million and a median of -$21.6 million in 2023 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax sank 269.68% in 2025 and soared 32.72% in 2026, its largest moves.
- Tracing AVBP's Profit After Tax over 4 years: stood at -$21.2 million in 2023, then increased by 2.64% to -$20.6 million in 2024, then sank by 74.3% to -$36.0 million in 2025, then dropped by 20.46% to -$43.3 million in 2026.
- Business Quant data shows AVBP's Profit After Tax at -$43.3 million in Q1 2026, -$36.0 million in Q4 2025, and -$34.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | -43.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.32 Mn |
| Dec 31, 2025 | -35.96 Mn |
| Sep 30, 2025 | -34.75 Mn |
| Jun 30, 2025 | -31.40 Mn |
| Mar 31, 2025 | -64.39 Mn |
| Dec 31, 2024 | -20.63 Mn |
| Sep 30, 2024 | -20.56 Mn |
| Jun 30, 2024 | -21.87 Mn |
| Mar 31, 2024 | -17.42 Mn |
| Dec 31, 2023 | -21.19 Mn |
| Sep 30, 2023 | -14.40 Mn |
| Jun 30, 2023 | -21.57 Mn |
| Mar 31, 2023 | -12.17 Mn |